The Medicine Maker / Authors / Roisin McGuigan

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a Deputy Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Bearfaced Research

October 17, 2018

A new method for discovering antibiotics makes use of an unusual source of complex microbial communities

1 min read

Bearfaced Research

The True Cost of Falsified Medicine

October 17, 2018

A recent review and meta-analysis highlights the huge impact of fake and substandard drugs on health, trust in healthcare, and the economy

1 min read

The True Cost of Falsified Medicine

Injectable Innovation

October 17, 2018

A company looks to give the humble injection an inventive makeover with a new competition

1 min read

Injectable Innovation

Time for Pharma to Deliver?

October 17, 2018

For the vast majority of pharmaceutical products, data on safety for pregnant and lactating women and their fetuses and babies is not available. But going without essential medication is not the right solution – failing to treat health conditions could lead to equal or increased risk for mother and child. Here, we seek the path to a more enlightened approach.

1 min read

Time for Pharma to Deliver?

Let’s Talk About Mental Health

September 12, 2018

A recent survey examined the relationships – or lack thereof – between pharma companies and mental health patient groups

1 min read

Let’s Talk About Mental Health

Too Many Cooks

August 15, 2018

Thought that most companies understood good manufacturing practice? Think again – there are always a few bad eggs

1 min read

Too Many Cooks

Bringing Alzheimer’s in from the Cold

August 15, 2018

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease? Here, we gain insight from a small but pioneering company and researchers in the Alzheimer’s research space to discover that – with the support of the wider community – there are significant reasons to be hopeful.

1 min read

Bringing Alzheimer’s in from the Cold

Recommended